Krishna Institute of Medical Sciences Ltd. share price target

We retain our BUY recommendation with a TP price of Rs 1,570/share.

Regional leader with sustainable growth story

KIMS has planned to add incremental bed capacity by 50% over the next 36-40 months. Furthermore, it has the highest return ratios with RoIC of 32% in the industry exhibiting low Capex per bed (Rs 36 Lc/bed) and high EBIT margins (22.7%).

Robust performance, Covid benefit visible

Regional leader with clinical excellence

region, 2) clinical excellence with affordable pricing, 3) immense scope for growing presence in adjoining markets through organic/inorganic route, 4) aggregate bed capacity of 3,064, with more than 2,500 operational beds as on...

region, 2) clinical excellence with affordable pricing, 3) immense scope for growing presence in adjoining markets through organic/inorganic route, 4) aggregate bed capacity of 3,064, with more than 2,500 operational beds as on...

Krishna Institute Of Medical Sciences Limited IPO Note Issue Open: June 16 June 18, 2021 Price Band: Rs. 815 825 (Discount of Rs.40 for all eligible employees) *Issue Size: 25,984,780 eq shares (Fresh issue of 2,424,242 eq sh +offer for Sale of 23,560,538 eqs h ) Issue Size: Rs.2117.8 2143.7.2cr Reservation for: QIB atleast 75% eq sh Non Institutional Upto 15% eq sh Retail Upto 10% eq sh Employees Rs.20 cr

KIMS owns one of the largest hospital chains in AP and Telangana. It reported | 1340.1 crore of revenues and | 381.0 crore of adjusted EBITDA in FY21, the highest in AP and Telangana. It has 3,064 beds as of 9MFY21,...

Krishna Institute of Medical Sciences Limited is one of the largest corporate healthcare groups in South India specially in AP and Telangana. It provides multi-disciplinary integrated healthcare services, with a focus on primary secondary, tertiary care and quaternary healthcare. Company operates 9 multi-specialty hospitals under the KIMS Hospitals brand, with an aggregate bed capacity of